Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 12, 2026 16:02 ET | Source: Serotonin

Serotonin Centers Opens Naperville Location at Block 59, Marking Brand’s Entry into the Chicago Market

Serotonin Centers opens its first Illinois location at Block 59 in Naperville, bringing physician-led longevity and aesthetic care to Chicagoland.
February 11, 2026 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health

NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservati
February 05, 2026 10:13 ET | Source: Keto-Mojo

Introducing Community by Keto-Mojo – A Supportive, Expert-Led Space to Help People Succeed in Ketosis and Beyond

Keto-Mojo launches Community—a private, expert-led platform offering daily support for sustainable keto and metabolic health success.
February 05, 2026 09:27 ET | Source: Serotonin

Serotonin Anti-Aging Center to Open Lake Nona Location This Spring, Expanding Orlando Presence

Serotonin Centers to open Lake Nona this spring, marking its 4th Orlando location, 15th nationwide, delivering physician-led longevity and anti-aging care.
February 04, 2026 08:00 ET | Source: Noom Inc

The Noom Engagement Report: New Data Shows that the GLP-1 Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest

Most-engaged members lost 25.2% more weight at week 40 and persisted 2.2x longer on medication program than least-engaged members using the Noom app.
February 03, 2026 08:00 ET | Source: Body360 Fit

Body360 Fit Announces Launch of Private One-on-One Personal Training in Beverly Grove

Los Angeles, CA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Body360 Fit is excited to announce the launch of its private personal training services in Beverly Grove. Led by expert personal trainer Christian...
January 23, 2026 07:30 ET | Source: Alveus Therapeutics Inc

Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity

PHILADELPHIA, Pennsylvania and COPENHAGEN, Denmark, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Alveus Therapeutics, Inc. (“Alveus”), a clinical-stage biotechnology company developing next-generation...
January 22, 2026 05:00 ET | Source: Resalis Therapeutics SRL

Resalis Therapeutics Appoints Sandor Batkai as Medical Director

Torino, Italy, January 22 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, today announced the appointment of Sandor Batkai, MD, PhD, as Medical Director. Dr....
January 21, 2026 19:25 ET | Source: Cowboy Colostrum

Colostrum Supplements for Weight Loss: How Consumers Compare IgG Potency, Gut Health Claims, and Sourcing Standards in 2026

Searches for "best colostrum supplement for weight loss" rise as consumers evaluate options like Cowboy Colostrum based on sourcing and IgG.
January 08, 2026 07:30 ET | Source: Alveus Therapeutics Inc

Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases

Financing supports Phase 2 development of ALV-100, IND filing of ALV-200 and advancement of additional programs across the R&D pipeline ALV-100, a bifunctional GIPR antagonist / GLP-1R agonist,...